Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
92 /100
CRITICAL RISK
Score updated Aug 28, 2026

CODX — Co-Diagnostics, Inc. Dilution Risk Tracker

Track CODX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CODX — Get alerts when the score changes →

As of August 28, 2026, Co-Diagnostics, Inc. (CODX) has a DilutionWatch DilutionScore of 92/100, rated CRITICAL dilution risk. Co-Diagnostics, Inc. has a market capitalization of $31.44M, 6.25M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $5.18M, 3.29M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
95
📊 Float Risk
60
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 58%
💰 Capital Raise model 75%
• Critical: only 2.3 months cash remaining
• Active shelf registration ($5M, 16% of market cap)
📜 Warrant Exercise model 60%
• Massive warrant overhang: 53% of shares outstanding
• Warrant risk score very high (90/100)
🔄 Reverse Split model est. 15%
• Only 2 months cash — financial pressure
🔔 Track CODX — Get forecast alerts →

Market Data

Market Cap$31.44M
Shares Outstanding6.25M
Float3.50M
Cash$5.90M
Debt$3.82M
Short InterestN/A

Institutional Holdings

10 institutional holders · 50.6K shares
#1 Private Advisory Group LLC 41.4K shares
#2 UBS Group AG 7.4K shares
#3 Summit Financial Wealth Advisors, LLC 1.3K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest348.7K
Days to Cover1.0
% of Float10.0%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2019-12-31
EFFECT EFFECT 2026-05-29
S-3 SHELF 2026-05-28
4 INSIDER TRANSACTION 2026-05-27
4 INSIDER TRANSACTION 2026-05-27
Full SEC filing analysis available with free account

Recent News

Factual CODX Dilution Snapshot

Co-Diagnostics, Inc. (CODX) has a DilutionScore of 92/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track CODX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CODX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Med Devices sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CODX
CODX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.